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 Abstract    
Introduction: Claudin-4 (CLDN4) is a transmembrane protein, responsible for cellular contact and organization. A 
different expression of claudin 4 in the endometrium, depending on the menstrual cycle and with peak at the aim of 
the ‘implantation window’, has been observed. CLDN4 is believed to play an important role in embryo implantation.
The aim: The aim of the study was to compare the mRNA CLDN4 expression levels in two subgroups of infertile 
women (idiopathic infertility or minimal endometriosis) and compare them to fertile controls.
Method: The study included 36 women with idiopathic infertility and 24 with minimal endometriosis. The control 
group comprised 26 women. Eutopic endometrium samples were collected with a Pipelle device during the implan-
tation window. Firstly, mRNA was extracted from the endometrium and reverse transcribed into cDNA. Real time 
PCR was used for the assessment of relative expression levels.
Results: The observed transcription level of CLDN4 did not differ statistically between the studied groups, but was 
significantly higher when compared to controls.
Conclusions: Exceedingly high levels of CLDN4 might negatively influence fertility rates.
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 Streszczenie 
Wstęp: Klaudyna 4 (CLDN4) jest białkiem transbłonowym, odpowiedzialnym m.in. za  wzajemny kontakt komórek 
i ich organizację. W endometrium zaobserwowano zmienne natężenie ekspresji CLDN4, zależne od fazy cyklu, 
z maksimum w „oknie implantacyjnym”. Zakłada się, że CLDN4 może odgrywać istotną rolę w procesie implantacji 
zarodka. 
Cel pracy: Celem pracy było porównanie poziomu mRNA CLDN4 w grupach kobiet niepłodnych z niepłodnością 
idiopatyczną i endometriozą minimalnego stopnia w odniesieniu do grupy kontrolnej.
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Introduction
Embryo	implantation	depends	on	a	close	interaction	between	
the	embryo	and	the	endometrium	[1].	Faulty	implantation	might	
lead	to	many	problems	including	infertility,	miscarriage,	IUGR	
and	 hypertension	 in	 pregnancy	 [2,	 3,	 4].	 Despite	 diagnostic	
advances	 in	 the	 reproductive	 field,	 the	 cause	 of	 infertility	
continues	to	be	idiopathic	in	about	10%	of	couples	[5].	Also,	the	
reasons	behind	infertility	in	patients	with	minimal	endometriosis	
remain	 to	be	elucidated	 [6].	Proper	early	dialogue	between	 the	
embryo	and	the	endometrium	warrants	successful	pregnancy.
While	great	 strides	have	been	made	 to	detect	poor	quality	
of	the	embryo,	either	by	morphologic	or	by	genetic	indices,	the	
endometrial	 part	 of	 receptivity	 remains	 poorly	 understood	 [7].	
Thanks	to	recent	advances	in	genetic	technologies,	such	as	gene	
chip	matrices,	we	are	now	able	to	compare	thousands	of	genes	
simultaneously	between	various	 times	of	 the	endometrial	cycle	
[8].	Pinpointing	the	‘implantation	window’,	that	is	the	period	of	
maximal	endometrial	receptivity,	allows	for	precise	comparison	
of	up-	and	down-regulated	genes,	that	might	prove	indispensable	
for	successful	implantation	to	occur.
Claudin-4	(CLDN4)	is	one	of	the	genes	that	were	found	to	
be	 significantly	 up-regulated	 during	 the	 period	 of	 endometrial	
receptivity.	 The	 first	 paper	 describing	 the	 up-regulation	 of	
claudin-4	was	the	work	of	Kao	et	al.	[9]	Later	their	results	were	
confirmed	 by	 two	 independent	 researchers,	 namely	 Rijsjewik	
and	Giudice	[10,	11].	Claudin-4	is	an	integral	membrane	protein	
and	a	member	of	a	large	family	of	transmembrane	tissue-specific	
proteins,	 that	are	essential	components	of	 the	intercellular	tight	
junction	 and	 regulate	 paracellular	 ion	 flow	 and	 cell	 polarity	
[12].	Claudin-4	is	found	on	nearly	all	epithelial	and	endothelial	
cells,	including	endometrial	tissue.	As	such,	it	might	contribute	
significantly	to	establishing	the	connection	between	the	embryo	
and	the	endometrial	surface,	as	well	as	play	a	role	in	cell-to-cell	
signaling	 pathways	 [9,	 10,	 13].	 In	 humans,	 claudin-4	was	first	
described	by	Katahira	[14].	The	aberrant	expression	of	claudin-4	
was	 noted	 in	 various	 cancers	 [15,	 16,	 17,	 18,	 19,	 20,	 21,	 22].	
Recently,	its	role	in	the	pathogenesis	of	endometriosis	has	been	
brought	to	attention	[23,	24].	
Therefore,	we	decided	to	test	the	claudin-4	mRNA	expression	
levels	 in	women	with	idiopathic	infertility	and	infertile	women	
with	 minimal	 endometriosis	 and	 compare	 those	 results	 with	
endometrial	expression	levels	of	claudin-4	of	women	with	proven	
fertility.
Materials and methods
Patients
The	study	was	conducted	at	 the	Division	of	Reproduction,	
Department	of	Obstetrics	and	Gynecology,	Poznan	University	of	
Medical	Sciences,	Poland.	
Only	those	infertile	patients	in	whom	either	all	diagnostic	tests	
were	negative	or	those	patients	who	presented	only	with	minimal	
endometriosis	were	included	in	the	study.	The	following	tests	were	
performed	 in	 each	 couple:	 semen	 analysis,	 ovulation	 tracking,	
hysterosalpingography,	 hormone	 studies	 and	 laparoscopy	 with	
hysteroscopy.	We	gathered	36	idiopathic	infertility	patients	and	
24	infertile	patients	with	minimal	endometriosis,	as	assessed	by	
laparoscopy	 and	histology,	 according	 to	 the	American	Fertility	
Society	[25].	
Mean	duration	of	infertility	in	each	group	was	3.4	years	(1-5	
years)	and	3.2	years	(1.2-6	years),	respectively.	Also,	26	patients,	
matched	for	age,	with	at	least	one	child,	no	negative	history	of	
infertility	and	endometriosis,	no	miscarriages,	were	enrolled	 in	
the	study	as	controls.	Those	patients	were	admitted	to	the	hospital	
for	 non-endometrial	 diseases,	 and	 were	 approached	 to	 donate	
the	endometrium.	The	study	protocol	was	approved	by	the	local	
ethical	committee,	and	the	patients	signed	an	informed	consent	
form.	None	of	the	patients	in	the	study	and	the	control	groups	had	
taken	any	hormonal	preparations	for	at	least	three	months	prior	
to	the	study.
Collection of samples and RNA isolation
All	 patients	 from	 the	 study	 and	 control	 groups	 had	 a	
biopsy	 sample	 taken	 7-9	 days	 after	 the	 ovulation,	 confirmed	
by	 ultrasound	 follicular	 tracking.	The	 endometrial	 sample	was	
placed	 in	RNAlaterTM	buffer	 from	Qiagen	 (Hilden,	Germany)	
and	frozen	till	extraction.	
The	isolation	of	total	RNA	was	done	with	the	use	of	RNAeasy	
Mini	 Kit	 (Qiagen,	 Germany).	 QiaShredder	 columns	 (Qiagen)	
were	 used	 for	 homogenization	 according	 to	 the	manufacturers	
instructions.	The	total	mRNA	was	treated	with	QantiTect	Reverse	
Transcription	(Qiagen)	to	acquire	cDNA.	
Primers design and qPCR reaction
RNA	 specific	 primers	 for	 RealTime	 PCR	 were	 created	
with	 the	 Primer3	 software	 (http://frodo.wi.mit.edu/primer3)	
based	 on	 the	 mRNA	 (ENSG00000189143)	 sequence	 from	
ENSEMBL	database	 (http://www.ensembl.org/index.html).	The	
Metoda: Plan badań uzyskał zgodę komisji bioetycznej. Do badań zakwalifikowano 36 kobiet z niepłodnością idio-
patyczną, 24 z kobiety endometriozą minimalnego stopnia. Grupa kontrolna obejmowała 26 kobiet. 
Materiał badawczy stanowiło eutopowe endometrium, pobrane pipellą w oknie implantacyjnym. Z bioptatów 
wyizolowano RNA. cDNA uzyskano przy pomocy odwrotnej transkrypcji. Do wyznaczenia względnego poziomu 
transkrypcji zastosowano metodę real-time PCR. 
Wyniki: Poziom transkryptu CLDN4 nie różnił się w sposób istotny statystycznie pomiędzy grupami badanymi, ale 
był istotnie statystycznie wyższy w obu grupach badanych w odniesieniu do grupy kontrolnej.  
Wniosek: Zbyt wysoki poziom ekspresji CLDN4 może mieć związek z zaburzonym rozrodem. 
 Słowa kluczowe: klaudyna / endometrium / niepłodność idiopatyczna / endometrioza /
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thermodynamic	features	of	designed	primers	were	first	checked	
in	 OligoAnalyzer1.2	 software,	 next	 specificity	 of	 constructed	
primers	was	checked	against	BLAST	database	(http://blast.ncbi.
nlm.nih.gov/Blast.cgi).		The	following	primers	were	constructed:	
GAPDH	 -	 forward:	 ACAGTCAGCCGCATCTTCTT	 and	
reverse:	 ACGACCAAATCCGTTGACTC	 and	 for	 claudin	
4	 -	 forward:	 TCTGTCTGCCTGCATCTC	 and	 reverse:	
AAGGCCTCAGCCATACTC.		
The	resulting	103bp	cDNA	product	was	checked	on	agarose	
gel	 to	 confirm	 the	 specificity	 of	 primer	 sets.	 Additionally,	
second	 derivative	 analysis	 melting	 curve	 product	 in	 Real	
Time	 PCR	 reaction	 of	 these	 primer	 sets	 was	 used	 to	 confirm	
the	 specificity.	 The	 resulting	 cDNA	 samples	 were	 used	 as	 the	
matrix	 for	 RealTime	 PCR	 which	 was	 conducted	 in	 duplicate,	
on	RotorGene	3000	RealTime	thermocycler	(Corbett	Research).	
The	optimized	protocol	was	used	with	the	mastermix	including	
HotStart	 polymerase	 (DyNAmo	 HS	 SYBRGreen	 qPCR	 Kit	
from	 Finnzymes,	 Espoo,	 Finland).	 The	 thermal	 profile	 was	
as	 follows:	 denaturation	 at	 950C,	 15min;	 amplification	 and	
quantification	at	940C	for	10sec,	followed	by	55°C	for	25sec	and	
finally	720C	for	30sec;	followed	by	first	data	acquisition	at	790C.	
The	 thermocycler	was	set	 to	40	runs.	 	After	 that	process	720C,	
10min	was	 run	 and	next	melting	 curve	was	 run,	 from	720C	 to	
950C,	rising	by	0.50C	with	each	step	with	continuous	fluorescence	
measurement.	 The	 expression	 of	 claudin-4	 was	 established	
according	 to	 the	 reference	 gene,	 namely	 glyceraldehyde-3-
phosphate	dehydrogenase	(GAPDH),	whose	expression	in	cells	
is	universally	considered	as	constant	across	the	menstrual	cycle.	
The	mean	GAPDH	expression	levels	did	not	differ	significantly	
among	the	groups.	
Statistical analysis.
For	 statistical	 analysis,	 SigmaStat3.5	 software	 was	 used.	
The	analysis	of	the	results	was	based	on	the	Kruskal-Wallis	One	
Way	Analysis	 of	Variance	on	Ranks	 assessment;	 p	<	0.05	was	
considered	statistically	significant.
Results
We	observed	statistically	significant	differences	in	CLDN4	
relative	transcript	levels	in	eutopic	endometria	between	controls	
and	patients	with	idiopathic	infertility	and	between	controls	and	
women	with	minimal	endometriosis.	The	relative	levels	of	claudin	
mRNA	expression	were	statistically	significantly	lower	in	fertile	
controls	when	compared	 to	 the	studied	groups.	However,	 there	
was	 no	 difference	 in	 the	 CLDN4	 relative	 transcription	 levels	
between	 both	 groups	 of	 infertile	 patients	 (idiopathic	 infertility	
and	 endometriosis).	 The	 results	 are	 presented	 in	 Table	 I	 and	
scatter	diagram,	Figure	1.
Discussion
Infertility	 is	 a	 disease	 that	 affects	many	 couples	 trying	 to	
conceive	 a	 child.	The	natural	 fecundability	 in	 a	monthly	 cycle	
is	 estimated	 to	 be	 around	 20-33%	 [26].	 Part	 of	 the	 blame	 for	
such	 low	chances	 for	successful	pregnancy	might	be	attributed	
to	 embryo	 defects,	 like	 aneuploidy,	 found	 especially	 in	 older	
women	[27,	28,	29].	
Advances	 in	 Assisted	 Reproductive	 Technology	 (ART)	
allowed	 clinicians	 to	 assess	 embryo	 quality	 and	 its	 future	
potential	for	 implantation	by	means	of	grading	its	morphology,	
fragmentation	status,	and	recently	also	its	genetic	makeup	owing	
to	 Preimplantation	 Genetic	 Diagnosis	 [30-32].	 However,	 even	
with	such	sophisticated	technologies,	the	clinical	pregnancy	rate	
remains	at	a	disappointing	30%	level	at	the	best	IVF	clinics	[33].	
Therefore,	 it	 is	 clear	 that	 the	 endometrium	 plays	 an	 important	
role	in	implantation.	Understanding	the	mechanisms	behind	the	
implantation	and	the	ways	to	control	it	would	translate	into	better	
outcomes	for	patients.	About	40%	of	patients	with	endometriosis	
are	infertile.	The	reasons	for	infertility	in	high	grade	endometriosis	
are	 well	 understood,	 while	 the	 mechanisms	 behind	 infertility	
in	 minimal	 endometriosis,	 without	 the	 presence	 of	 adhesions	
or	 endometriomas,	 are	 less	 clear	 [34].	 Numerous	 factors,	
including	 hormones,	 antibodies	 and	 changed	 immunologic	
status,	are	speculated	to	contribute	to	infertility	of	women	with	
endometriosis	 [35,	 36].	 Recently,	 the	 role	 of	 intrinsic	 changes	
within	 the	 eutopic	 endometrium	of	women	with	 endometriosis	
has	 been	 brought	 up	 by	 some	 researchers	 [37].	Whether	 these	
changes	 are	 the	 cause	 or	 effect	 of	 endometriosis,	 and	whether	
they	could	be	considered	to	be	causative	agents	for	infertility	that	
often	accompanies	this	disease,	remains	to	be	elucidated.
Table I. Target mRNA levels were corrected to the amount of cDNA and expressed 
as multiplicity of these cDNA copies in the calibrator. The obtained results were 
compared against the control group using the Mann-Whitney Rank Sum Test. 
Group n median
min.-max. 
value of 
CLDN4 relative 
transcript level
P
Healthy controls 26 63.35 2.63-650 -
Women with 
idiopathic infertility 36 164.0 0.46-828 0.027
Women with minimal 
endometriosis 24 192.5 11.3-1090 0.025
Figure 1. Relative transcript level CLDN4 in the endometrium of women from the 
studied and control groups. To normalize the quantity of transcripts in each sample, 
CLDN4 mRNA levels were normalized to the amount of GAPDH cDNA. Horizontal 
lines correspond to the values of medians.
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Up	till	now,	the	search	for	the	so-called	markers	of	endometrial	
receptivity	 has	 relied	 on	 studying	 single	 factors	 or	 family	 of	
genes.	Gene	matrix	analysis	allowed	studying	thousands	of	genes	
at	a	single	pass.	This	in	turn	allowed	pinpointing	candidates	for	
markers	of	endometrial	receptivity.	Some	of	these	up-	and	down	
regulated	 genes	 might	 be	 indispensable	 for	 the	 implantation	
process,	while	others	might	turn	out	to	be	redundant.
To	the	best	of	our	knowledge,	this	paper	is	the	first	attempt	
to	 elucidate	 the	 potential	 role	 of	 claudin	 4	 in	 reproduction	 in	
natural	cycles.	We	selected	women	with	idiopathic	infertility	and	
infertile	women	with	 endometriosis	 as	 the	potential	 candidates	
for,	as	yet	undiscovered,	errors	in	genetic	code	that	might	lead	to	
infertility.	We	hypothesized	that	some	cases	of	infertility	in	those	
patients	might	be	attributed	to	aberrant	expression	of	claudin	4	
mRNA	in	the	endometrial	tissue.
The	role	of	claudin-4	in	reproduction	is	not	well	understood.	
Studies	 from	 Husjewic	 assessed	 the	 role	 of	 claudin-4	 in	 ion	
transport	 through	 the	 pores	 in	 tight	 junctions	 between	 cells,	
favoring	chloride	influx,	while	blocking	the	influx	of	sodium	ions	
[5].	With	the	initial	attachment	of	the	embryo	to	the	endometrial	
surface	and	 further	deeper	 invasions,	 the	environment	between	
them	 emerges	 as	 a	 major	 contributor	 to	 either	 pregnancy	
success	 or	 failure.	 Since	 numerous	 studies	 proved	 that	 claudin	
mRNA	expression	is	upregulated	during	the	midluteal	phase	of	
the	endometrial	cycle,	one	might	speculate	 that	 the	function	of	
claudin-4	during	the	implantation	process	might	be	an	important	
one	[9,	10].
We	 found	 statistically	 significant	 differences	 in	 claudin-4	
mRNA	expression	levels	between	the	studied	groups	and	fertile	
controls.	Patients	with	minimal	endometriosis	often	suffer	from	
infertility.	 Some	 studies	 suggested	 that	 eutopic	 endometrial	
samples	 from	women	with	endometriosis	differ	markedly	from	
eutopic	endometria	obtained	from	women	without	 this	disease.	
Authors	of	these	studies	showed	that	apoptosis,	MMP	3,	MMP7	
are	 differently	 regulated	 within	 the	 eutopic	 endometrium	 of	
women	with	and	without	endometriosis	[38,	39,	40,	41].	
Contrary	 to	 recently	published	 study	 from	Pan	 et	 al.,	who	
found	no	significant	differences	in	eutopic	endometrium	between	
the	studied	groups,	both	at	the	mRNA	and	protein	level,	we	found	
higher	levels	of	mRNA	expression	in	the	eutopic	endometrium	of	
women	diagnosed	with	minimal	endometriosis	when	compared	
to	 fertile	controls	 [24].	These	authors	however,	also	 found	 that	
ectopic	 endometrial	 lesions	 had	 significantly	 down-regulated	
claudin-4	 expression	when	 compared	 to	 eutopic	 endometrium,	
which	might	suggest	that	an	altered	environment	of	the	peritoneal	
cavity	 in	 women	 with	 endometriosis	 could	 ‘transform’	 the	
biochemical	and	genetic	pathways	of	 shed	eutopic	endometrial	
cells,	 allowing	 them	 to	 grow	 and	 function	 as	 endometriosis	
implants.	On	the	basis	of	the	result	of	our	study	we	might	speculate,	
that	the	up-regulation	in	claudin	expression	is	an	intrinsic	factor	
that	is	already	present	in	the	eutopic	endometrium.	These	changes	
might	prove	responsible	for	the	survival	and	invasive	potential	of	
endometrial	cells	found	in	women	with	endometriosis.
We	also	 found	a	higher	 expression	of	 claudin-4	mRNA	 in	
the	group	of	patients	with	idiopathic	infertility	when	compared	
to	 fertile	 controls.	 Women	 with	 idiopathic	 infertility	 are	
particularly	 difficult	 to	 treat	 as	 all	 the	 treatments	 offered	 are	
empirical	as	best.	Those	patients	are	ideal	candidates	for	studies	
of,	as	yet	undiscovered,	causes	of	human	infertility.	Taking	into	
consideration	 the	 results	 of	 our	 investigation,	 it	 seems	 safe	 to	
conclude	that	aberrant	expression	might	be	a	common	cause	of	
infertility	in	selected	group	of	patients.	
We	 cannot	 rule	 out	 that	 patients	with	 idiopathic	 infertility	
might	have	microscopic	lesions	of	endometriosis,	therefore	some	
of	them	might	exhibit	the	same	changes	in	claudin	expression	in	
the	eutopic	endometrium	as	women	with	endometriosis.
Our	results	are	confirmed	by	the	study	of	Serafini	et	al.,	who	
assessed	 the	 chances	 of	 conception	 and	 pregnancy	 in	 women	
undergoing	 IVF	programs	 [42].	They	proved	 that	women	with	
low	claudin-4	 in	a	midluteal	biopsy	 taken	 in	a	cycle	preceding	
the	 IVF	 treatment,	 had	 the	 highest	 chances	 of	 successful	
implantation	and	pregnancy.	The	results	were	similar	even	after	
correction	for	differences	of	age.	The	question	remains	whether	
that	could	be	viewed	as	a	proof	of	detrimental	role	of	claudin-4	in	
the	implantation	process	and,	if	so,	why	the	gene	matrix	studies	
revealed	strong	up-regulation	of	the	claudin-4	genes	during	the	
implantation	window.	There	is	accumulating	evidence	that	IVF	
treatment	influences	a	number	of	factors	within	the	endometrium,	
at	the	protein,	receptor	and	genetic	levels	[16].	
Since	 the	 collection	 of	 samples	 took	 place	 in	 a	 non-
conceptive	cycle,	one	cannot	draw	conclusions	as	to	the	effects	
of	 powerful	 hormonal	 stimulation	 used	 for	 controlled	 ovarian	
hyperstimulation	protocols	on	the	expression	of	different	markers	
of	implantation.	It	could	be	speculated	that	hormonal	treatments	
have	 selectively	 ‘corrected’	 the	 low	 expression	 of	 claudin-4	 in	
those	 patients,	 resulting	 in	 better	 pregnancy	 rates	 compared	 to	
women	with	‘normal’	claudin-4	levels.	There	are	also	reports	that	
link	progesterone	levels	to	higher	claudin-4	expression	[43].	
In	 a	 cited	 study,	 all	women	 received	1200	mg	daily	doses	
of	micronized	progesterone,	 and	 that	 treatment	could	 influence	
or	‘rescue’	claudin	expression,	resulting	in	improved	pregnancy	
rates.	 Such	 positive	 response	 to	 progestin	 supplementation,	
namely	increased	expression	of	claudin	4	and	better	pregnancy	
rates,	might	explain,	on	the	molecular	level,	why	some	patients	
might	benefit	from	this	kind	of	therapy.
Conclusion
In	 conclusion,	 it	 seems	 that	 exceedingly	 high	 levels	 of	
claudin	 expression	 in	 the	 eutopic	 endometrium	 play	 a	 role	
in	 infertility	 in	 both	 women	 with	 minimal	 endometriosis	 and	
idiopathic	infertility.	The	role	of	claudin	in	 the	development	of	
endometriosis	remains	to	be	elucidated.
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